🔎 Trials Near Me

Akèy › Kasinom selil skuam › Massachusetts › Boston

Etid klinik pou Kasinom selil skuam nan Boston, MA

8 etid pou Kasinom selil skuam ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Ap rekriteFaz 3
  • Boston Medical Center, Boston
Laj 60 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04892173

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Ap rekriteFaz 1/2
  • Tufts Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06561685

Toripalimab With Chemotherapy for Sinus Cancer

Ap rekriteFaz 2
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT06940180

PDT For Induction Therapy For Head And Neck Cancer

Ap rekriteFaz 2
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07214987

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 3
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Apr 9, 2026 · NCT06064877

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Oct 8, 2025 · NCT04370587

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Ap rekriteFaz 1
  • Dana Farber/Partners Cancer Care Inc, Boston
Laj 18 ak plis · Tout sèks · Mizajou Aug 15, 2025 · NCT04429542

Etid Kasinom selil skuam nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.